ATXI: Multiplikator Forward P/S Avenue Therapeutics Inc

Lambang korporat lan logo Avenue Therapeutics, Inc (ATXI)

Regulatory challenges with the FDA have weakened the intellectual property patent protection of Avenue Therapeutics (ATXI). Meanwhile, an asset-light model minimizes costs, directing resources into R&D for subsequent distribution through partners. The forward price-to-sales valuation trend visualizes market expectations, where the level reflects the current magnitude. The ultimate success of the business is based on the safety of new therapies and the efficiency of engagement with medical networks.

Avenue Therapeutics, Inc. - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ATXI (periode 04.07.2022 - 17.11.2026)

Rincian metrik lan analitis perusahaan avenuetx.com (ATXI)

Pambiji fundamental:avenuetx.com ATXI
Sampel barang Avenue Therapeutics

This ratio reflects the relationship between the market value of Avenue Therapeutics (ATXI) and its expected annual revenue, allowing for an assessment of the extent to which the company's future successes are priced in. By analyzing the forward P/S of the business, an investor can compare market expectations with the efficiency of the production and clinical research outsourcing model, which minimizes capital expenditures for Avenue Therapeutics during therapy scaling.

Analisis pesaing

Multiplikator Forward P/S BIIB (Biogen Idec)|Rasio kapitalisasi marang dodolan sing dikarepake Neurocrine Corp (NBIX)|RGC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AXSM (Axsome Therapeutics)|ACAD: Multiplikator Forward P/S|Xenon Pharmaceuticals Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Pharma|SUPN: Rega forward marang dodolan|Multiplikator Forward P/S CPRX|Multiplikator Forward P/S denalitherapeutics.com (DNLI)|Multiplikator Forward P/S HRMY (Harmony Biosciences Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Biohaven (BHVN)|Amylyx Corp - Multiplikator Forward P/S|TRVI - Multiplikator Forward P/S|Praxis Precision Medicines Inc (PRAX) - Rasio rega marang prakiraan pendapatan|AVXL - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CeriBell|Multiplikator Forward P/S Prothena Corporation plc|Rasio rega marang prakiraan pendapatan Alector Therapeutics (ALEC)|Annexon Inc. - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan omeros.com OMER|neurogene.com (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|acimmune.com - Multiplikator Forward P/S|Voyager Therapeutics Inc (VYGR) - Multiplikator forward rega marang pendapatan|Neumora Corp (NMRA) - Rasio rega marang prakiraan pendapatan|Scilex Holding Company, Inc. (SCLX) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TVGN|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alpha Cognition Inc. ACOG|Rasio rega marang prakiraan pendapatan cogrx.com (CGTX)|Rasio kapitalisasi marang dodolan sing dikarepake Inhibikase Therapeutics, Inc.|Multiplikator Forward P/S SAVA (Cassava Sciences Inc)|Multiplikator Forward P/S Assertio Holdings, Inc. ASRT|COYA - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Vistagen (VTGN)|OVID: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Acumen Pharmaceuticals Inc. (ABOS)|Multiplikator forward rega marang pendapatan CRVO|Kapitalisasi marang prakiraan pendapatan ATHE (Alterity Therapeutics)|Rasio rega marang prakiraan pendapatan Clene Nanomedicine (CLNN)|PEPG (PepGen) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|Rega forward marang dodolan RLMD|ANVS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grace Therapeutics Inc|AIFF: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Klotho Neurosciences Inc (KLTO)|Rasio rega marang prakiraan pendapatan neurosense-tx.com|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Reviva Pharmaceuticals Holdings Inc. RVPH|Rasio rega marang prakiraan pendapatan MetaVia Inc. (MTVA)|Rasio kapitalisasi marang dodolan sing dikarepake NeurAxis Inc|Multiplikator Forward P/S HSDT (heliusmedical.com)|Rega forward marang dodolan PASG|NEUP: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Minerva Neurosciences Inc|Athira Pharma (ATHA) - Rasio rega marang prakiraan pendapatan|Addex Therapeutics, Ltd. - Rega forward marang dodolan|ALZN (Alzamend Neuro) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep cyclerion.com CYCN|Multiplikator Forward P/S PTIX|KTTA - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S CRGT (Cortigent, Inc.)|BrainStorm Cell Therapeutics Inc. - Rasio rega marang prakiraan pendapatan|Cara Therapeutics Inc. - Multiplikator Forward P/S|Chromocell Therapeutics (CHRO) - Multiplikator forward rega marang pendapatan|ELYM: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - Multiplikator Forward P/S|Marinus - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S NKGN|NRBO (NeuroBo Pharmaceuticals) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics Inc)|Rasio kapitalisasi marang dodolan sing dikarepake Synaptogenix Inc. (SNPX)|TRVN - Rasio rega marang prakiraan pendapatan|vigilneuro.com (VIGL) - Multiplikator forward rega marang pendapatan|WENA: Multiplikator Forward P/S|Cerevel Therapeutics, Inc. (CERE) - Multiplikator Forward P/S